Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Phase I/II Trial of a Combination of Anti-CD3/CD7 Immunotoxins for Steroid-Refractory Acute Graft-versus-Host Disease.

Groth C, van Groningen LFJ, Matos TR, Bremmers ME, Preijers FWMB, Dolstra H, Reicherts C, Schaap NPM, van Hooren EHG, IntHout J, Masereeuw R, Netea MG, Levine JE, Morales G, Ferrara JL, Blijlevens NMA, van Oosterhout YVJM, Stelljes M, van der Velden WJFM.

Biol Blood Marrow Transplant. 2019 Apr;25(4):712-719. doi: 10.1016/j.bbmt.2018.10.020. Epub 2018 Nov 3.

PMID:
30399420
2.

Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group.

Westers TM, Cremers EM, Oelschlaegel U, Johansson U, Bettelheim P, Matarraz S, Orfao A, Moshaver B, Brodersen LE, Loken MR, Wells DA, Subirá D, Cullen M, Te Marvelde JG, van der Velden VH, Preijers FW, Chu SC, Feuillard J, Guérin E, Psarra K, Porwit A, Saft L, Ireland R, Milne T, Béné MC, Witte BI, Della Porta MG, Kern W, van de Loosdrecht AA; IMDSFlow Working Group.

Haematologica. 2017 Feb;102(2):308-319. doi: 10.3324/haematol.2016.147835. Epub 2016 Oct 6.

3.

Monocytes and macrophages in flow: an ESCCA initiative on advanced analyses of monocyte lineage using flow cytometry.

Lambert C, Preijers FWMB, Yanikkaya Demirel G, Sack U.

Cytometry B Clin Cytom. 2017 May;92(3):180-188. doi: 10.1002/cyto.b.21280. Epub 2015 Dec 12.

4.

Fifteen years of external quality assessment in leukemia/lymphoma immunophenotyping in The Netherlands and Belgium: A way forward.

Preijers FW, van der Velden VH, Preijers T, Brooimans RA, Marijt E, Homburg C, van Montfort K, Gratama JW; Section Immunological and Molecular Cell Diagnostics of the Foundation for Quality Assessment in Medical Laboratories(SKML).

Cytometry B Clin Cytom. 2016 May;90(3):267-78. doi: 10.1002/cyto.b.21266. Epub 2015 Jul 31.

5.
6.

Selective expansion of human natural killer cells leads to enhanced alloreactivity.

Eissens DN, Michelo CM, Preijers FW, van Cranenbroek B, van Houwelingen K, van der Meer A, Joosten I.

Cell Mol Immunol. 2014 Mar;11(2):160-8. doi: 10.1038/cmi.2013.56. Epub 2013 Nov 18.

7.

High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study.

Terwijn M, van Putten WL, Kelder A, van der Velden VH, Brooimans RA, Pabst T, Maertens J, Boeckx N, de Greef GE, Valk PJ, Preijers FW, Huijgens PC, Dräger AM, Schanz U, Jongen-Lavrecic M, Biemond BJ, Passweg JR, van Gelder M, Wijermans P, Graux C, Bargetzi M, Legdeur MC, Kuball J, de Weerdt O, Chalandon Y, Hess U, Verdonck LF, Gratama JW, Oussoren YJ, Scholten WJ, Slomp J, Snel AN, Vekemans MC, Löwenberg B, Ossenkoppele GJ, Schuurhuis GJ.

J Clin Oncol. 2013 Nov 1;31(31):3889-97. doi: 10.1200/JCO.2012.45.9628. Epub 2013 Sep 23.

PMID:
24062400
8.

A "complicated" fracture: a Philadelphia chromosome-positive myeloid sarcoma of the bone.

van Groningen LF, Preijers FW, Jansen JH, Hebeda KM, van der Velden WJ.

Ann Hematol. 2013 Sep;92(9):1287-8. doi: 10.1007/s00277-013-1691-7. Epub 2013 Feb 13. No abstract available.

PMID:
23404583
9.

Absolute lymphocyte count predicts the response to new influenza virus H1N1 vaccination in pediatric cancer patients.

Mavinkurve-Groothuis AM, van der Flier M, Stelma F, van Leer-Buter C, Preijers FW, Hoogerbrugge PM.

Clin Vaccine Immunol. 2013 Jan;20(1):118-21. doi: 10.1128/CVI.00585-12. Epub 2012 Nov 21.

10.

OMIP-010: a new 10-color monoclonal antibody panel for polychromatic immunophenotyping of small hematopoietic cell samples.

Preijers FW, Huys E, Moshaver B.

Cytometry A. 2012 Jun;81(6):453-5. doi: 10.1002/cyto.a.22056. Epub 2012 Apr 24. No abstract available.

11.

Defining early human NK cell developmental stages in primary and secondary lymphoid tissues.

Eissens DN, Spanholtz J, van der Meer A, van Cranenbroek B, Dolstra H, Kwekkeboom J, Preijers FW, Joosten I.

PLoS One. 2012;7(2):e30930. doi: 10.1371/journal.pone.0030930. Epub 2012 Feb 3.

12.

Implementation of flow cytometry in the diagnostic work-up of myelodysplastic syndromes in a multicenter approach: report from the Dutch Working Party on Flow Cytometry in MDS.

Westers TM, van der Velden VH, Alhan C, Bekkema R, Bijkerk A, Brooimans RA, Cali C, Dräger AM, de Haas V, Homburg C, de Jong A, Kuiper-Kramer PE, Leenders M, Lommerse I, te Marvelde JG, van der Molen-Sinke JK, Moshaver B, Mulder AB, Preijers FW, Schindhelm RK, van der Sluijs A, van Wering ER, Westra AH, van de Loosdrecht AA; Working Party on Flow Cytometry in MDS of Dutch Society of Cytometry (NVC).

Leuk Res. 2012 Apr;36(4):422-30. doi: 10.1016/j.leukres.2011.09.015. Epub 2011 Oct 6.

PMID:
21982641
13.

Quality controls of cryopreserved haematopoietic progenitor cells (peripheral blood, cord blood, bone marrow).

Rosskopf K, Ragg SJ, Worel N, Grommé M, Preijers FW, Braakman E, Schuurhuis GJ, van Riet I, Wendel S, Fontão-Wendel R, Lazar A, Goldman M, Halpenny M, Giulivi A, Letcher B, McGann L, Korhonen M, Arvola A, Humpe A, Buwitt-Beckmann U, Wiesneth M, Schauwecker P, Schrezenmeier H, Bönig H, Henschler R, Seifried E, Accorsi P, Bonfini T, Takanashi M, van Beckhoven JM, Brand A, Gounder D, Wong A, Dooccey R, Forrest E, Galea G, Smythe J, Pawson R, Reems JA, Oh J, Reesink HW, Panzer S.

Vox Sang. 2011 Oct;101(3):255-75. doi: 10.1111/j.1423-0410.2011.01471.x. No abstract available.

PMID:
21923889
14.

The new violet laser dye, Krome Orange, allows an optimal polychromatic immunophenotyping based on CD45-KO gating.

Preijers FW, Huys E, Leenders M, Nieto L, Gautherot E, Moshaver B.

J Immunol Methods. 2011 Sep 30;372(1-2):42-51. doi: 10.1016/j.jim.2011.06.025. Epub 2011 Jul 14.

PMID:
21781971
15.

Adult metachromatic leukodystrophy treated by allo-SCT and a review of the literature.

de Hosson LD, van de Warrenburg BP, Preijers FW, Blijlevens NM, van der Reijden BA, Kremer HP, Lefeber DJ, Allebes WA, Al-Ali H, Niederwieser DW, Schaap NP, Schattenberg AV.

Bone Marrow Transplant. 2011 Aug;46(8):1071-6. doi: 10.1038/bmt.2010.252. Epub 2010 Nov 1. Review.

PMID:
21042305
16.

A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients.

Lesterhuis WJ, de Vries IJ, Aarntzen EA, de Boer A, Scharenborg NM, van de Rakt M, van Spronsen DJ, Preijers FW, Figdor CG, Adema GJ, Punt CJ.

Br J Cancer. 2010 Oct 26;103(9):1415-21. doi: 10.1038/sj.bjc.6605935. Epub 2010 Oct 5.

17.

Rapamycin and MPA, but not CsA, impair human NK cell cytotoxicity due to differential effects on NK cell phenotype.

Eissens DN, Van Der Meer A, Van Cranenbroek B, Preijers FW, Joosten I.

Am J Transplant. 2010 Sep;10(9):1981-90. doi: 10.1111/j.1600-6143.2010.03242.x.

18.

CD3+/CD19+-depleted grafts in HLA-matched allogeneic peripheral blood stem cell transplantation lead to early NK cell cytolytic responses and reduced inhibitory activity of NKG2A.

Eissens DN, Schaap NP, Preijers FW, Dolstra H, van Cranenbroek B, Schattenberg AV, Joosten I, van der Meer A.

Leukemia. 2010 Mar;24(3):583-91. doi: 10.1038/leu.2009.269. Epub 2009 Dec 24.

PMID:
20033055
19.

Deficiency of Dol-P-Man synthase subunit DPM3 bridges the congenital disorders of glycosylation with the dystroglycanopathies.

Lefeber DJ, Schönberger J, Morava E, Guillard M, Huyben KM, Verrijp K, Grafakou O, Evangeliou A, Preijers FW, Manta P, Yildiz J, Grünewald S, Spilioti M, van den Elzen C, Klein D, Hess D, Ashida H, Hofsteenge J, Maeda Y, van den Heuvel L, Lammens M, Lehle L, Wevers RA.

Am J Hum Genet. 2009 Jul;85(1):76-86. doi: 10.1016/j.ajhg.2009.06.006. Epub 2009 Jul 2.

20.

Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes.

van de Loosdrecht AA, Alhan C, Béné MC, Della Porta MG, Dräger AM, Feuillard J, Font P, Germing U, Haase D, Homburg CH, Ireland R, Jansen JH, Kern W, Malcovati L, Te Marvelde JG, Mufti GJ, Ogata K, Orfao A, Ossenkoppele GJ, Porwit A, Preijers FW, Richards SJ, Schuurhuis GJ, Subirá D, Valent P, van der Velden VH, Vyas P, Westra AH, de Witte TM, Wells DA, Loken MR, Westers TM.

Haematologica. 2009 Aug;94(8):1124-34. doi: 10.3324/haematol.2009.005801. Epub 2009 Jun 22.

21.

Clinical grade Treg: GMP isolation, improvement of purity by CD127 Depletion, Treg expansion, and Treg cryopreservation.

Peters JH, Preijers FW, Woestenenk R, Hilbrands LB, Koenen HJ, Joosten I.

PLoS One. 2008 Sep 8;3(9):e3161. doi: 10.1371/journal.pone.0003161.

22.

Evaluation of 'out-of-specification' CliniMACS CD34-selection procedures of hematopoietic progenitor cell-apheresis products.

Braakman E, Schuurhuis GJ, Preijers FW, Voermans C, Theunissen K, van Riet I, Fibbe WE, Slaper-Cortenbach I.

Cytotherapy. 2008;10(1):83-9. doi: 10.1080/14653240701787650.

PMID:
18202977
23.

Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis.

Vonk MC, Marjanovic Z, van den Hoogen FH, Zohar S, Schattenberg AV, Fibbe WE, Larghero J, Gluckman E, Preijers FW, van Dijk AP, Bax JJ, Roblot P, van Riel PL, van Laar JM, Farge D.

Ann Rheum Dis. 2008 Jan;67(1):98-104. Epub 2007 May 25. Erratum in: Ann Rheum Dis. 2008 Feb;67(2):280.

PMID:
17526554
24.

Flow cytometric CD34+ stem cell enumeration: lessons from nine years' external quality assessment within the Benelux countries.

Levering WH, Preijers FW, van Wieringen WN, Kraan J, van Beers WA, Sintnicolaas K, van Rhenen DJ, Gratama JW.

Cytometry B Clin Cytom. 2007 May;72(3):178-88.

25.

A mediastinal mass after donor lymphocyte infusion for relapse of chronic myeloid leukemia after allogeneic stem cell transplantation.

Schattenberg AV, Baynes C, van Dijk MC, Koster A, van Cleef PH, Preijers FW, Hermus A, Raemaekers JM.

Leuk Lymphoma. 2006 Jun;47(6):1188-90. No abstract available.

PMID:
16840222
26.

Three-color flowcytometric analysis of mature and immature hematological malignancies. A guideline of the Dutch Foundation for Immunophenotyping of Hematological Malignancies (SIHON).

van Wering ER, van Lochem EG, Leenders M, van der Sluijs-Gelling AJ, Wind H, Gratama JW, Kraan J, Preijers FW.

J Biol Regul Homeost Agents. 2004 Jul-Dec;18(3-4):313-26.

PMID:
15786698
27.

Enumeration of antigen-specific CD8+ T lymphocytes by single-platform, HLA tetramer-based flow cytometry: a European multicenter evaluation.

Heijnen IA, Barnett D, Arroz MJ, Barry SM, Bonneville M, Brando B, D'hautcourt JL, Kern F, Tötterman TH, Marijt EW, Bossy D, Preijers FW, Rothe G, Gratama JW; European Working Group on Clinical Cell Analysis.

Cytometry B Clin Cytom. 2004 Nov;62(1):1-13.

28.

Production of anti-CD3 and anti-CD7 ricin A-immunotoxins for a clinical pilot study.

van Oosterhout YV, van Emst JL, Bakker HH, Preijers FW, Schattenberg AV, Ruiter DJ, Evers S, Koopman JP, de Witte T.

Int J Pharm. 2001 Jun 19;221(1-2):175-86.

PMID:
11397579
29.

Relationship of the CD22 immunotoxin dose and the tumour establishment in a SCID mice model.

Van Horssen PJ, Preijers FW, Van Oosterhout YV, Eling WM, De Witte T.

Leuk Lymphoma. 2000 Nov;39(5-6):591-9.

PMID:
11342342
30.

A combination of anti-CD3 and anti-CD7 ricin A-immunotoxins for the in vivo treatment of acute graft versus host disease.

van Oosterhout YV, van Emst L, Schattenberg AV, Tax WJ, Ruiter DJ, Spits H, Nagengast FM, Masereeuw R, Evers S, de Witte T, Preijers FW.

Blood. 2000 Jun 15;95(12):3693-701.

PMID:
10845899
31.

Persistent symptoms in former UNTAC soldiers are not associated with shifted cytokine balance.

Soetekouw PM, De Vries M, Preijers FW, Van Crevel R, Bleijenberg G, Van Der Meer JW.

Eur J Clin Invest. 1999 Nov;29(11):960-3.

PMID:
10583441
32.
33.

Influence of cytotoxicity enhancers in combination with human serum on the activity of CD22-recombinant ricin A against B cell lines, chronic and acute lymphocytic leukemia cells.

van Horssen PJ, van Oosterhout YV, Evers S, Backus HH, van Oijen MG, Bongaerts R, de Witte T, Preijers FW.

Leukemia. 1999 Feb;13(2):241-9.

34.

Rationale for the use of immunotoxins in the treatment of HIV-infected humans.

Van Oijen MG, Preijers FW.

J Drug Target. 1998;5(2):75-91. Review.

PMID:
9588864
35.

The role of the different CD34 epitopes in detection and positive selection of CD34+ bone marrow and peripheral blood stem cells.

Croockewit AJ, Raymakers RA, Preijers FW, Vierwinden G, de Witte TJ.

Scand J Immunol. 1998 Jan;47(1):82-90.

36.
37.

Cytotoxic potency of CD22-ricin A depends on intracellular routing rather than on the number of internalized molecules.

van Horssen PJ, van Oosterhout YV, de Witte T, Preijers FW.

Scand J Immunol. 1995 Jun;41(6):563-9.

PMID:
7770726
38.

Effect of isotype on internalization and cytotoxicity of CD19-ricin A immunotoxins.

van Oosterhout YV, van den Herik-Oudijk IE, Wessels HM, de Witte T, van de Winkel JG, Preijers FW.

Cancer Res. 1994 Jul 1;54(13):3527-32.

39.

A quantitative flow cytometric method for the determination of immunotoxin-induced cell kill in marrow grafts.

van Oosterhout YV, Preijers FW, Meijerink JP, Pennings AH, de Witte T.

Prog Clin Biol Res. 1994;389:89-95. No abstract available.

PMID:
7700943
40.
41.

Cytotoxicity of CD3-ricin A chain immunotoxins in relation to cellular uptake and degradation kinetics.

van Oosterhout YV, Preijers FW, Wessels HM, de Witte T.

Cancer Res. 1992 Nov 1;52(21):5921-5.

42.

Autologous transplantation of bone marrow purged in vitro with anti-CD7-(WT1-) ricin A immunotoxin in T-cell lymphoblastic leukemia and lymphoma.

Preijers FW, De Witte T, Wessels JM, De Gast GC, Van Leeuwen E, Capel PJ, Haanen C.

Blood. 1989 Aug 15;74(3):1152-8.

PMID:
2473811
43.

Cytotoxic potential of anti-CD7 immunotoxin (WT1-ricin A) to purge ex vivo malignant T cells in bone marrow.

Preijers FW, De Witte T, Wessels JM, Meyerink JP, Haanen C, Capel PJ.

Br J Haematol. 1989 Feb;71(2):195-201.

PMID:
2784323
44.

Relationship between internalization and cytotoxicity of ricin A-chain immunotoxins.

Preijers FW, Tax WJ, De Witte T, Janssen A, vd Heijden H, Vidal H, Wessels JM, Capel PJ.

Br J Haematol. 1988 Nov;70(3):289-94.

PMID:
3264717
45.

The development of non-responsiveness to immunotherapy with monoclonal anti-idiotypic antibodies in a patient with B-CLL.

Allebes WA, Preijers FW, Haanen C, Capel PJ.

Br J Haematol. 1988 Nov;70(3):295-300.

PMID:
3207626
46.

Human T lymphocyte differentiation antigens as target for immunotoxins or complement-mediated cytotoxicity.

Preijers FW, De Witte T, Rijke-Schilder GP, Tax WJ, Wessels JM, Haanen C, Capel PJ.

Scand J Immunol. 1988 Aug;28(2):185-94.

PMID:
3261884
47.

Different susceptibilities of normal T cells and T cell lines to immunotoxins.

Preijers FW, Tax WJ, Wessels JM, Capel PJ, De Witte T, Haanen C.

Scand J Immunol. 1988 May;27(5):533-40.

PMID:
3259720
48.

Treatment of chronic lymphocytic leukaemia with monoclonal anti-idiotypic antibody.

Capel PJ, Preijers FW, Allebes WA, Haanen C.

Neth J Med. 1985;28(3):112-8. No abstract available.

PMID:
3982571

Supplemental Content

Loading ...
Support Center